Asiedu, Mercy N.
Agudogo, Júlia S.
Dotson, Mary E.
Skerrett, Erica
Krieger, Marlee S.
Lam, Christopher T.
Agyei, Doris
Amewu, Juliet
Asah-Opoku, Kwaku
Huchko, Megan
Schmitt, John W.
Samba, Ali
Srofenyoh, Emmanuel
Ramanujam, Nirmala
Clinical trials referenced in this document:
Documents that mention this clinical trial
A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system
https://doi.org/10.1038/s41598-020-72219-9
Documents that mention this clinical trial
A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system
https://doi.org/10.1038/s41598-020-72219-9
Funding for this research was provided by:
Duke Global Health Institute, Duke University
National Institutes of Health (5R01CA193380-05)
Article History
Received: 5 April 2020
Accepted: 25 August 2020
First Online: 6 October 2020
Competing interests
: MNA, MSK, and NR, have founded a company called Calla Health Foundation to commercialize the Callascope. They and other team members (JSA, ESk, CTL) have developed technologies related to this work where the investigators or Duke may benefit financially if this system is sold commercially. For the concept of this system a patent has been awarded to MNA, JSA, CTL and NR with the title: "Colposcopes and mammoscopes having curved ends and flat ends, associated methods, and speculum-free imaging methods". U.S. Patent Application No. 16/089,522. This does not alter the authors' adherence to Scientific Report’s policies on sharing data and materials. Other authors declare no competing interets.